Thirteen-week repeated dose oral toxicity study of coenzyme Q10 in rats

Journal of Toxicological Sciences

Volumn 32, Issue 4, 2007, Pages 437-448

  Honda, Kumiko ^a   Tominaga, Sayumi ^a   Oshikata, Takafumi ^a   Kamiya, Kouichi ^a   Hamamura, Masao ^a   Kawasaki, Tsuneshirou ^b   Wakigawa, Kouichi ^b  

^a Panapharm Laboratories Co   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

Coenzyme Q10; Rats; Subchronic toxicology

Indexed keywords

UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BLOOD CHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; FOOD INTAKE; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; MALE; NONHUMAN; OPHTHALMOSCOPY; RAT; TOXICOLOGICAL PARAMETERS;

RATTUS;

EID: 35648968107     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.32.437     Document Type: Article

References (31)

1. Chiba, T., Watanabe, T., Kume, Y., Sugiyama, K. and Shiojiri, H. (1972): Toxicological studies of Ubiquinone-10 (1) acute toxicity test in rats and mice & subacute and chronic toxicity tests in rats. Pharmacometrics, 6, 769-779.
2. Crane, F.L., Hatefi, Y., Lester, R.L. and Widmer, C. (1957): Isolation of a quinone from beef heart mitochondria. Biochem. Biophys. Acta, 25, 220-221.
3. Digiesi, V., Cantini, F., Oradei, A., Bisi, G., Guarino, G.C., Brocchi, A., Bellandi, F., Mancini, M. and Littarru, G.P. (1990): Coenzyme Q10 in essential hypertension. Mol. Aspects Med., 15, s257-263.
4. Dunnett, C.W. (1964): New tables for multiple comparisons with a control. Biometrics, 20, 482-491.
5. th edition, p.6. Hapner Publishining Company, New York.
6. Hofman-Bang, C., Rehnqvist, N., Swedberg, K., Wiklund, I. and Astrom, H. (1995): Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. J. Card. Fail., 1, 101-107.
7. Ikeda, K., Suzuki, Y. and Yoshimura, I. (2005): Mutagenicity of coenzyme Q10. J. Nutr Sci. Vitaminol., 51, 45-47.
8. Imai, K. and Hirose, M. (2000): Thyroid/Parathyroid. In: Dokuseibyourisosikigaku, The Japanese Society of Toxicologic Pathology (Ed), The Japanese Society of Toxicologic Pathology, Nagoya, pp.435-446.
9. Kalen, A., Appelkvist, E.L. and Dallner, G. (1989): Age-related changes in the lipid composition of rat and human tissues. Lipids, 24, 579-584.
10. Kitano, M., Hosoe, K., Fukutomi, N., Hidaka, T., Imai, N. and Kawabe, M. (2004): 28-Day repeated dose toxicity study of dried microorganism in rats. Food Chem. Toxicol., 42, 1817-1824.
11. Kitano, M., Hosoe, K., Fukutomi, N., Hidaka, T., Ohta, R., Yamakage, K. and Hara, T. (2006): Evaluation of the mutagenic potential of ubidecarenone using three short-term assays. Food Chem. Toxicol., 44, 364-370.
12. Langsjoen, P.H., Vadhanavikit, S. and Folkers, K. (1985): Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc. Natl. Acad. Sci. USA, 82, 4240-4244.
13. Losco, P. and Harleman, H. (1992): Normal Development, Growth, and Aging of the Lymph Node, Blood and Lymphoid System. In: Pathobiology of the Aging Rat. VOLUME 1. Mohr, U., Dungworth, D.L., Capen, C.C. (Eds). ILSI Press, Washington, D.C., pp.49-73.
14. Mann, H.B. and Whitney, D.R. (1947): On a test of whether one of two random variables is stochastically larger than other. Ann. Math. Stat., 18, 50-60.
15. Mohr, D., Bowry, V.W. and Stocker, R. (1992): Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochem. Biophys. Acta, 1126, 247-254.
16. Morisco, C., Trimarco, B. and Condorelli, M. (1993): Effect of coenzyme Q10 therapy in patients with congestive heart failure: A long-term multicenter randomized study. Clin. Investig., 71, S134-136.
17. Morton, R.A. (1961): Ubiquinones (Coenzyme Q), Ubichromenol, and related substances. Vitamins & Hormones, 19, 1-42.
18. Mukai, K., Kikuchi, S. and Urano, S. (1990): Stopped-flow kinetic study of the regeneration reaction of tocopheroxyl radical by reduced ubiquinone-10 in solution. Biochim. Biophys. Acta, 1035, 77-82.
19. Nagayabu, T., Kitazaki, T., Kandori, H., Nishida, N., Naeshiro, I. and Sato, S. (1999): Crj:CD(SD)IGS Rats and the Effects of a Commercial Low Protein Diet on the Biological Parameters Used in Repeated-Dose Toxicity Studies at the Hikari Branch, Drug Safety Research Laboratories in Takeda Chemical Industries, Ltd., Biological Reference Data on CD(SD)IGS Rats, pp.89-104.
20. Noack, H., Kube, U. and Augustin, W. (1994): Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria. Free Radic. Res., 20, 375-386.
21. Nohl, H., Gille, L. and Kozlov, A.V. (1999): Critical aspects of the antioxidant function of coenzyme Q in biomembranes. Biofactors, 9, 155-61.
22. Rosenfeldt, F.L., Haas, S.J., Krum, H., Hadj, A., Ng, K., Leong, J.Y. and Watts, G.F. (2007): Coenzyme Q10 in the treatment of hypertension: A meta-analysis of the clinical trials. J. Hum. Hypertens., 21, 297-306.
23. Sander, S., Coleman, C.I., Patel, A.A., Kluger, J. and White, C.M. (2004): The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J. Card. Fail., 12, 464-472.
24. Shunk, C.H., Linn, B.O., Wong, E.L., Wittreich, P.E., Robinson, F.M. and Folkers, K. (1958): Coenzyme Q II Synthesis of 6-farnesyl- and 6-phytyl-derivatives of 2,3-demethoxy-5-methylbenzoquinone and related analogs. J. Am. Chem. Soc., 80, 4753.
25. Singh, R.B., Neki, N.S., Kartikey, K., Pella, D., Kumar, A., Niaz, M.A. and Thakur, A.S. (2003): Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol. Cell Biochem., 246, 75-82.
26. Singh, R.B., Wander, G.S., Rastogi, A., Shukla, P.K., Mittal, A., Sharma, J.P., Mehrotra, S.K., Kapoor, R. and Chopra, R.K. (1998): Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc. Drugs Ther., 12, 347-353.
27. Steel, R.G.D. (1959): A multiple comparison rank sum test: Treatments versus control. Biometrics, 15, 560-572.
28. Suzanne, B.N. (1990): 4. Salivary Glands. In Pathology of the Fischer Rat. (Gray, A.B., Scot, L.E., Michael, R.E., Charles, A.M.Jr. and William, F.M., eds.), pp31-42, Academic Press, Inc.
29. Tsunenari, I., Iwasaki, S., Kawaguchi, T., Ashida, Y. and Kadota, T. (2000): Background Data of Crj:CD(SD)IGS Rats Dosed with Distilled Water Orally for 4, 13 or 26 Weeks. Biological Reference Data on CD(SD)IGS Rats, pp.75-78.
30. Williams, K.D., Maneke, J.D., AbdelHameed, M., Hall, R.L., Palmer, T.E., Kitano, M. and Hidaka, T. (1999): 52-Week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery. J. Agric. Food Chem., 47, 3756-3763.
31. Young, A.J., Johnson, S., Steffens, D.C. and Doraiswamy, P.M. (2007): Coenzyme Q10: a review of its promise as a neuroprotectant. CNS Spectr., 12, 62-68.